Evaluation of Serum 25-Hydroxyvitamin D, Ferritin, and CA 15-3 Levels in Women with Breast Cancer
Baghdad Journal of Biochemistry and Applied Biological Sciences · 10.04.2026 · 7 (2) · 125-132
DOI: 10.47419/bjbabs.v7i2.440 ↗Kurz gefasst
Fachartikel in der Zeitschrift Baghdad Journal of Biochemistry and Applied Biological Sciences, online erschienen am 10.04.2026. Verfasst von Marwa Adel Hussein und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and objective: The most malignant disease among women in Iraq is breast cancer, rendering the identification of reliable biomarkers a priority for initial detection and disease monitoring. Despite the broad usage of CA 15-3 as a tumor-associated marker, its diagnostic value is limited. Vitamin D deficiency and altered iron metabolism, as reflected in serum ferritin levels, have also been implicated in cancer development. This study aims to examine levels of 25-hydroxyvitamin D [25(OH)D], ferritin, and CA 15-3 in women with breast cancer compared with healthy controls, and to assess their diagnostic performance.
Methods
The study carried out a comparative cross-sectional examination of 50 women suffering from breast cancer and 50 healthy controls of matching age. The 25(OH)D and ferritin levels were identified using electrochemiluminescence immunoassays, while the quantification of CA 15-3 was performed via enzyme-linked immunosorbent assay. Data analysis relied on SPSS version 29.
Results
The patients exhibited notably lower levels of 25(OH)D serum (18.9 ± 2.4 ng/ml) in comparison to the controls (34.6 ± 3.6 ng/ml; P < 0.001). Ferritin levels were higher in patients (45.3 ± 5.3 ng/ml) than controls (31.0 ± 3.9 ng/ml; P < 0.001). CA 15-3 was also markedly elevated in the patients (45.2 ± 2.5 U/ml) in comparison to the controls (17.9 ± 3.7 U/ml; P < 0.001). Correlation analysis within patients showed a moderate positive association between CA 15-3 and 25(OH)D (r = 0.50, 95% CI 0.24–0.69, P < 0.001) and a weaker correlation with ferritin (r = 0.28, 95% CI 0.00–0.53, P = 0.047). Receiver operating characteristic analysis showed good diagnostic discrimination: 25(OH)D (AUC = 0.85, 95% CI 0.77–0.92), ferritin (AUC = 0.83, 95% CI 0.74–0.91), and CA 15-3 (AUC = 0.99, 95% CI 0.97–1.00).
Conclusions
Iraqi women with breast cancer exhibited significantly reduced vitamin D and elevated ferritin alongside increased CA 15-3. While CA 15-3 provided the highest diagnostic accuracy, both vitamin D deficiency and elevated ferritin demonstrated additional discriminative value. A combined biomarker approach may offer a more comprehensive strategy for disease assessment, and greater prospective research is recommended to verify these results.
Zitieren
APA
Hussein, M. A., Hadi, I. R., Al_Ward, M. A., & Güllü, M. (2026). Evaluation of Serum 25-Hydroxyvitamin D, Ferritin, and CA 15-3 Levels in Women with Breast Cancer. Baghdad Journal of Biochemistry and Applied Biological Sciences, 7(2), 125-132. https://doi.org/10.47419/bjbabs.v7i2.440
Vancouver
Hussein MA, Hadi IR, Al_Ward MA, Güllü M. Evaluation of Serum 25-Hydroxyvitamin D, Ferritin, and CA 15-3 Levels in Women with Breast Cancer. Baghdad Journal of Biochemistry and Applied Biological Sciences. 2026;7(2):125-132. doi:10.47419/bjbabs.v7i2.440
BibTeX
@article{Hussein2026,
author = {Hussein, Marwa Adel and Hadi, Ibrahim Ramzi and Al_Ward, Mais Adnan and Güllü, Mithat},
title = {Evaluation of Serum 25-Hydroxyvitamin D, Ferritin, and CA 15-3 Levels in Women with Breast Cancer},
journal = {Baghdad Journal of Biochemistry and Applied Biological Sciences},
year = {2026},
volume = {7},
number = {2},
pages = {125--132},
doi = {10.47419/bjbabs.v7i2.440}
}
EUVIMED